Skip to main content
SpringerLink
Log in

Preventive and Therapeutic Effect of Ganoderma (Lingzhi) on Renal Diseases and Clinical Applications

  • Chapter
  • First Online:
Ganoderma and Health

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 1182))

Abstract

The mechanisms of kidney diseases, such as acute kidney injury (AKI) and chronic kidney disease (CKD), have been intensively studied. Nonetheless, the morbidity and mortality of AKI and CKD increased in recent years. Recently, natural products have been increasingly recognized as an alternative source for treating renal diseases on account of the conventional experience and the multi-target characteristics. Ganoderma lucidum (G. lucidum, Lingzhi) has been used for centuries as nutraceuticals and alternative medicine to improve health and to treat numerous diseases. Benefiting from various biological activities, such as anti-oxidation, anti-inflammation, anti-tumor growth and metastasis, etc., G. lucidum has been proved to exhibit significant role in preventing and treating various kidney diseases. In this chapter, we review certain researches and provide comprehensive insights into the renoprotective effects of G. lucidum.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lin ZB, Zhang HN (2004) Anti-tumor and immunoregulatory activities of Ganoderma lucidum and its possible mechanisms. Acta Pharmacol Sin 25:1387–1395

    CAS  PubMed  Google Scholar 

  2. Chen S, Yong T, Zhang Y, Su J, Jiao C, Xie Y (2017) Anti-tumor and anti-angiogenic Ergosterols from Ganoderma lucidum. Front Chem 5:85

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Chu TT, Benzie IF, Lam CW, Fok BS, Lee KK, Tomlinson B (2012) Study of potential cardioprotective effects of Ganoderma lucidum (Lingzhi): results of a controlled human intervention trial. Br J Nutr 107:1017–1027

    Article  CAS  PubMed  Google Scholar 

  4. Morigiwa A, Kitabatake K, Fujimoto Y, Ikekawa N (1986) Angiotensin converting enzyme-inhibitory triterpenes from Ganoderma lucidum. Chem Pharm Bull 34:3025–3028

    Article  CAS  Google Scholar 

  5. Kabir Y, Kimura S, Tamura T (1988) Dietary effect of Ganoderma lucidum mushroom on blood pressure and lipid levels in spontaneously hypertensive rats (SHR). J Nutr Sci Vitaminol 34:433–438

    Article  CAS  PubMed  Google Scholar 

  6. Bhardwaj N, Katyal P, Sharma AK (2014) Suppression of inflammatory and allergic responses by pharmacologically potent fungus Ganoderma lucidum. Recent Patents Inflamm Allergy Drug Discov 8:104–117

    Article  CAS  Google Scholar 

  7. Wu H, Tang S, Huang Z, Zhou Q, Zhang P, Chen Z (2016) Hepatoprotective effects and mechanisms of action of triterpenoids from Lingzhi or Reishi medicinal mushroom Ganoderma lucidum (Agaricomycetes) on alpha-amanitin-induced liver injury in mice. Int J Med Mushrooms 18:841–850

    Article  PubMed  Google Scholar 

  8. Chiu HF, Fu HY, Lu YY, Han YC, Shen YC, Venkatakrishnan K, Golovinskaia O, Wang CK (2017) Triterpenoids and polysaccharide peptides-enriched Ganoderma lucidum: a randomized, double-blind placebo-controlled crossover study of its antioxidation and hepatoprotective efficacy in healthy volunteers. Pharm Biol 55:1041–1046

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Zhong D, Xie Z, Huang B, Zhu S, Wang G, Zhou H, Lin S, Lin Z, Yang B (2018) Ganoderma Lucidum polysaccharide peptide alleviates Hepatoteatosis via modulating bile acid metabolism dependent on FXR-SHP/FGF. Cell Physiol Biochem 49:1163–1179

    Article  PubMed  CAS  Google Scholar 

  10. Meneses ME, Martinez-Carrera D, Torres N, Sanchez-Tapia M, Aguilar-Lopez M, Morales P, Sobal M, Bernabe T, Escudero H, Granados-Portillo O, Tovar AR (2016) Hypocholesterolemic properties and prebiotic effects of Mexican Ganoderma lucidum in C57BL/6 mice. PLoS One 11:e0159631

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  11. Chang CJ, Lin CS, Lu CC, Martel J, Ko YF, Ojcius DM, Tseng SF, Wu TR, Chen YY, Young JD, Lai HC (2015) Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nat Commun 6:7489

    Google Scholar 

  12. Zhang W, Zhang Q, Deng W, Li Y, Xing G, Shi X, Du Y (2014) Neuroprotective effect of pretreatment with Ganoderma lucidum in cerebral ischemia/reperfusion injury in rat hippocampus. Neural Regen Res 9:1446–1452

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Joob B, Wiwanitkit V (2016) Linzhi (Ganoderma lucidum); evidence of its clinical usefulness in renal diseases. J Nephropharmacol 5:9–10

    Google Scholar 

  14. Venkatachalam MA, Griffin KA, Lan R, Geng H, Saikumar P, Bidani AK (2010) Acute kidney injury: a springboard for progression in chronic kidney disease. Am J Physiol Renal Physiol 298:F1078–F1094

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Venkatachalam MA, Weinberg JM, Kriz W, Bidani AK (2015) Failed tubule recovery, AKI-CKD transition, and kidney disease progression. J Am Soc Nephrol 26:1765–1776

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Vanmassenhove J, Kielstein J, Jorres A, Van Biesen W (2017) Management of patients at risk of acute kidney injury. Lancet 389:2139–2151

    Article  PubMed  Google Scholar 

  17. Koza Y (2016) Acute kidney injury: current concepts and new insights. J Injury Violence Res 8:58–62

    Google Scholar 

  18. Levey AS, James MT (2017) Acute kidney injury. Ann Intern Med 167:ITC66–ITC80

    Article  PubMed  Google Scholar 

  19. Szeto HH (2017) Pharmacologic approaches to improve mitochondrial function in AKI and CKD. J Am Soc Nephrol 28:2856–2865

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Yerramilli M, Farace G, Quinn J, Yerramilli M (2016) Kidney disease and the Nexus of chronic kidney disease and acute kidney injury: the role of novel biomarkers as early and accurate diagnostics. Vet Clin North Am Small Anim Pract 46:961–993

    Article  PubMed  Google Scholar 

  21. Webster AC, Nagler EV, Morton RL, Masson P (2017) Chronic kidney disease. Lancet 389:1238–1252

    Article  PubMed  Google Scholar 

  22. Breyer MD, Susztak K (2016) The next generation of therapeutics for chronic kidney disease. Nat Rev Drug Discov 15:568–588

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, Chen M, He Q, Liao Y, Yu X, Chen N, Zhang JE, Hu Z, Liu F, Hong D, Ma L, Liu H, Zhou X, Chen J, Pan L, Chen W, Wang W, Li X, Wang H (2012) Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 379:815–822

    Article  PubMed  Google Scholar 

  24. Murphy D, McCulloch CE, Lin F, Banerjee T, Bragg-Gresham JL, Eberhardt MS, Morgenstern H, Pavkov ME, Saran R, Powe NR, Hsu CY, C Centers for Disease, T Prevention Chronic Kidney Disease Surveillance (2016) Trends in prevalence of chronic kidney disease in the United States. Ann Intern Med 165:473–481

    Article  PubMed  PubMed Central  Google Scholar 

  25. Collaborators GCD, GBD (2017) Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in;195 countries and territories, 1980-2017: a systematic analysis for the Global Burden Of Disease Study 2017 (vol 392, pg 1736, 2018). Lancet 392(2018):2170–2170

    Google Scholar 

  26. Foreman KJ, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey M, Pletcher MA, Smith AE, Tang K, Yuan CW, Brown JC, Friedman J, He J, Heuton KR, Holmberg M, Patel DJ, Reidy P, Carter A, Cercy K, Chapin A, Douwes-Schultz D, Frank T, Goettsch F, Liu PY, Nandakumar V, Reitsma MB, Reuter V, Sadat N, Sorensen RJD, Srinivasan V, Updike RL, York H, Lopez AD, Lozano R, Lim SS, Mokdad AH, Vollset SE, Murray CJL (2018) Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet 392:2052–2090

    Article  PubMed  PubMed Central  Google Scholar 

  27. Gobe GC, Shen K (2015) Chinese herbal medicines and chronic kidney disease: a positive outcome in a large patient study in Taiwan. Kidney Int 88:1223–1226

    Article  PubMed  Google Scholar 

  28. Zhong D, Wang H, Liu M, Li X, Huang M, Zhou H, Lin S, Lin Z, Yang B (2015) Ganoderma lucidum polysaccharide peptide prevents renal ischemia reperfusion injury via counteracting oxidative stress. Sci Rep 5:16910

    Google Scholar 

  29. Su L, Liu L, Jia Y, Lei L, Liu J, Zhu S, Zhou H, Chen R, Lu HAJ, Yang B (2017) Ganoderma triterpenes retard renal cyst development by downregulating Ras/MAPK signaling and promoting cell differentiation. Kidney Int 92:1404–1418

    Article  CAS  PubMed  Google Scholar 

  30. Pillai TG, John M, Sara Thomas G (2011) Prevention of cisplatin induced nephrotoxicity by terpenes isolated from Ganoderma lucidum occurring in southern parts of India. Exp Toxicol Pathol 63:157–160

    Article  CAS  PubMed  Google Scholar 

  31. He CY, Li WD, Guo SX, Lin SQ, Lin ZB (2006) Effect of polysaccharides from Ganoderma lucidum on streptozotocin-induced diabetic nephropathy in mice. J Asian Nat Prod Res 8:705–711

    Article  CAS  PubMed  Google Scholar 

  32. Pan D, Zhang D, Wu J, Chen C, Xu Z, Yang H, Zhou P (2014) A novel proteoglycan from Ganoderma lucidum fruiting bodies protects kidney function and ameliorates diabetic nephropathy via its antioxidant activity in C57BL/6 db/db mice. Food Chem Toxicol 63:111–118

    Article  CAS  PubMed  Google Scholar 

  33. Yan YM, Wang XL, Zhou LL, Zhou FJ, Li R, Tian Y, Zuo ZL, Fang P, Chung AC, Hou FF, Cheng YX (2015) Lingzhilactones from Ganoderma lingzhi ameliorate adriamycin-induced nephropathy in mice. J Ethnopharmacol 176:385–393

    Article  CAS  PubMed  Google Scholar 

  34. Lai KN, Chan LY, Tang SC, Leung JC (2006) Ganoderma extract prevents albumin-induced oxidative damage and chemokines synthesis in cultured human proximal tubular epithelial cells. Nephrol Dialysis Transpl 21:1188–1197

    Article  CAS  Google Scholar 

  35. Yan YM, Ai J, Zhou LL, Chung AC, Li R, Nie J, Fang P, Wang XL, Luo J, Hu Q, Hou FF, Cheng YX (2013) Lingzhiols, unprecedented rotary door-shaped meroterpenoids as potent and selective inhibitors of p-Smad3 from Ganoderma lucidum. Org Lett 15:5488–5491

    Article  CAS  PubMed  Google Scholar 

  36. Dou M, Di L, Zhou LL, Yan YM, Wang XL, Zhou FJ, Yang ZL, Li RT, Hou FF, Cheng YX (2014) Cochlearols A and B, polycyclic meroterpenoids from the fungus Ganoderma cochlear that have renoprotective activities. Org Lett 16:6064–6067

    Article  CAS  PubMed  Google Scholar 

  37. Xiao GL, Liu FY, Chen ZH (2003) [Clinical observation on treatment of Russula subnigricans poisoning patients by Ganoderma lucidum decoction]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chin J Integr Tradition West Med 23:278–280

    Google Scholar 

  38. Futrakul N, Panichakul T, Butthep P, Futrakul P, Jetanalin P, Patumraj S, Siriviriyakul P (2004) Ganoderma lucidum suppresses endothelial cell cytotoxicity and proteinuria in persistent proteinuric focal segmental glomerulosclerosis (FSGS) nephrosis. Clin Hemorheol Microcirc 31:267–272

    Google Scholar 

  39. He L, Wei Q, Liu J, Yi M, Liu Y, Liu H, Sun L, Peng Y, Liu F, Venkatachalam MA, Dong Z (2017) AKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms. Kidney Int 92:1071–1083

    Article  PubMed  PubMed Central  Google Scholar 

  40. Lieberthal W, Levine JS (1996) Mechanisms of apoptosis and its potential role in renal tubular epithelial cell injury. Am J Phys 271:F477–F488

    CAS  Google Scholar 

  41. Kloner RA, Przyklenk K, Whittaker P (1989) Deleterious effects of oxygen radicals in ischemia/reperfusion. Resolved and unresolved issues. Circulation 80:1115–1127

    Article  CAS  PubMed  Google Scholar 

  42. Cao QZ, Lin ZB (2004) Antitumor and anti-angiogenic activity of Ganoderma lucidum polysaccharides peptide. Acta Pharmacol Sin 25:833–838

    Google Scholar 

  43. You YH, Lin ZB (2002) Protective effects of Ganoderma lucidum polysaccharides peptide on injury of macrophages induced by reactive oxygen species. Acta Pharmacol Sin 23:787–791

    Google Scholar 

  44. Qiu GX, Zhang XM, Xing GQ, Qiao XF, Shi XJ (2005) Protective effect of Ganoderma polysaccharide oral liquid on renal ischemia-reperfusion injury in rats. J Taishan Med Coll 26:536–538

    Google Scholar 

  45. Harris PC, Torres VE (2009) Polycystic kidney disease. Annu Rev Med 60:321–337

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Ong AC, Devuyst O, Knebelmann B, Walz G, Diseases E-EWGfIK (2015) Autosomal dominant polycystic kidney disease: the changing face of clinical management. Lancet 385:1993–2002

    Article  PubMed  Google Scholar 

  47. Gao J, Zhou H, Lei T, Zhou L, Li W, Li X, Yang B (2011) Curcumin inhibits renal cyst formation and enlargement in vitro by regulating intracellular signaling pathways. Eur J Pharmacol 654:92–99

    Article  CAS  PubMed  Google Scholar 

  48. Zhou H, Gao J, Zhou L, Li X, Li W, Li X, Xia Y, Yang B (2012) Ginkgolide B inhibits renal cyst development in in vitro and in vivo cyst models. Am J Physiol Renal Physiol 302:F1234–F1242

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Dasari S, Tchounwou PB (2014) Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol 740:364–378

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Gui X, Wang L, Chen X, Yang Y, Pei R, Ma X, Wang X (1999) Experimental study on the attenuation effect of cisplatin by Ganoderma lucidum injection. Chin J Integr Tradition West Med 19:76–77

    Google Scholar 

  51. Rossing P (2006) Diabetic nephropathy: worldwide epidemic and effects of current treatment on natural history. Curr Diab Rep 6:479–483

    Article  PubMed  Google Scholar 

  52. Li W, Mao C, Yin Q (2008) Effects of Ganoderma lucidum polysaccharides on the expression of matrix metalloproteinase-2/tissue inhibitor of metalloproteinase-2 in diabetic rat kidney. Chin J Gerontol 3:226–229

    Google Scholar 

  53. Jung KA, Kwak MK (2010) The Nrf2 system as a potential target for the development of indirect antioxidants. Molecules 15:7266–7291

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

Research in the author’s laboratory is supported by National Natural Science Foundation of China grants 81620108029, 81330074, 81261160507, and 81170632, Beijing Natural Science Foundation grant 7172113, Drug Discovery Program grant 2009ZX09301-010-30, the Research Fund for the Doctoral Program of Higher Education 20100001110047, the 111 project, and the International Science and Technology Cooperation Program of China 2012DFA11070.

Author information

Authors and Affiliations

  1. Department of Pharmacology, School of Basic Medical Sciences, Peking University, Beijing, China

    Xiaoqiang Geng, Dandan Zhong, Limin Su & Baoxue Yang

Authors
  1. Xiaoqiang Geng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dandan Zhong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Limin Su
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Baoxue Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Baoxue Yang .

Editor information

Editors and Affiliations

  1. Department of Pharmacology, School of Basic Medical Sciences, Peking University, Beijing, China

    Zhibin Lin

  2. Department of Pharmacology, School of Basic Medical Sciences, Peking University, Beijing, China

    Baoxue Yang

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Geng, X., Zhong, D., Su, L., Yang, B. (2019). Preventive and Therapeutic Effect of Ganoderma (Lingzhi) on Renal Diseases and Clinical Applications. In: Lin, Z., Yang, B. (eds) Ganoderma and Health. Advances in Experimental Medicine and Biology, vol 1182. Springer, Singapore. https://doi.org/10.1007/978-981-32-9421-9_10

Download citation

Publish with us

Policies and ethics

Search

Navigation